305 related articles for article (PubMed ID: 28264054)
1. Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality.
Beauparlant D; Rusert P; Magnus C; Kadelka C; Weber J; Uhr T; Zagordi O; Oberle C; Duenas-Decamp MJ; Clapham PR; Metzner KJ; Günthard HF; Trkola A
PLoS Pathog; 2017 Mar; 13(3):e1006255. PubMed ID: 28264054
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic Correlates of HIV-1 Macrophage Tropism.
Arrildt KT; LaBranche CC; Joseph SB; Dukhovlinova EN; Graham WD; Ping LH; Schnell G; Sturdevant CB; Kincer LP; Mallewa M; Heyderman RS; Rie AV; Cohen MS; Spudich S; Price RW; Montefiori DC; Swanstrom R
J Virol; 2015 Nov; 89(22):11294-311. PubMed ID: 26339058
[TBL] [Abstract][Full Text] [Related]
4. Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors.
Peters PJ; Duenas-Decamp MJ; Sullivan WM; Brown R; Ankghuambom C; Luzuriaga K; Robinson J; Burton DR; Bell J; Simmonds P; Ball J; Clapham PR
Retrovirology; 2008 Jan; 5():5. PubMed ID: 18205925
[TBL] [Abstract][Full Text] [Related]
5. Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropism.
O'Connell O; Repik A; Reeves JD; Gonzalez-Perez MP; Quitadamo B; Anton ED; Duenas-Decamp M; Peters P; Lin R; Zolla-Pazner S; Corti D; Wallace A; Wang S; Kong XP; Lu S; Clapham PR
J Virol; 2013 Jan; 87(1):187-98. PubMed ID: 23055568
[TBL] [Abstract][Full Text] [Related]
6. Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages.
Peters PJ; Bhattacharya J; Hibbitts S; Dittmar MT; Simmons G; Bell J; Simmonds P; Clapham PR
J Virol; 2004 Jul; 78(13):6915-26. PubMed ID: 15194768
[TBL] [Abstract][Full Text] [Related]
7. Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities.
Joseph SB; Arrildt KT; Swanstrom AE; Schnell G; Lee B; Hoxie JA; Swanstrom R
J Virol; 2014 Feb; 88(4):1858-69. PubMed ID: 24307580
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages.
Musich T; O'Connell O; Gonzalez-Perez MP; Derdeyn CA; Peters PJ; Clapham PR
Retrovirology; 2015 Mar; 12():25. PubMed ID: 25809903
[TBL] [Abstract][Full Text] [Related]
9. Stoichiometry for entry and binding properties of the Env protein of R5 T cell-tropic HIV-1 and its evolutionary variant of macrophage-tropic HIV-1.
Bonner X; Sondgeroth A; McCue A; Nicely N; Tripathy A; Spielvogel E; Moeser M; Ke R; Leiderman K; Joseph SB; Swanstrom R
mBio; 2024 Apr; 15(4):e0032124. PubMed ID: 38426750
[TBL] [Abstract][Full Text] [Related]
10. Macrophage-tropic HIV-1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5.
Salimi H; Roche M; Webb N; Gray LR; Chikere K; Sterjovski J; Ellett A; Wesselingh SL; Ramsland PA; Lee B; Churchill MJ; Gorry PR
J Leukoc Biol; 2013 Jan; 93(1):113-26. PubMed ID: 23077246
[TBL] [Abstract][Full Text] [Related]
11. The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors.
Rossi F; Querido B; Nimmagadda M; Cocklin S; Navas-Martín S; Martín-García J
Retrovirology; 2008 Oct; 5():89. PubMed ID: 18837996
[TBL] [Abstract][Full Text] [Related]
12. Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue.
Gonzalez-Perez MP; O'Connell O; Lin R; Sullivan WM; Bell J; Simmonds P; Clapham PR
Retrovirology; 2012 Mar; 9():20. PubMed ID: 22420378
[TBL] [Abstract][Full Text] [Related]
13. Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages.
Ghaffari G; Tuttle DL; Briggs D; Burkhardt BR; Bhatt D; Andiman WA; Sleasman JW; Goodenow MM
J Virol; 2005 Nov; 79(21):13250-61. PubMed ID: 16227248
[TBL] [Abstract][Full Text] [Related]
14. No detection of CD4-independent human immunodeficiency virus 1 envelope glycoproteins in brain tissue of patients with or without neurological complications.
Quitadamo B; Peters PJ; Koch M; Luzuriaga K; Cheng-Mayer C; Clapham PR; Gonzalez-Perez MP
Arch Virol; 2019 Feb; 164(2):473-482. PubMed ID: 30415390
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 cell-to-cell spread overcomes the virus entry block of non-macrophage-tropic strains in macrophages.
Han M; Cantaloube-Ferrieu V; Xie M; Armani-Tourret M; Woottum M; Pagès JC; Colin P; Lagane B; Benichou S
PLoS Pathog; 2022 May; 18(5):e1010335. PubMed ID: 35622876
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatic analysis of neurotropic HIV envelope sequences identifies polymorphisms in the gp120 bridging sheet that increase macrophage-tropism through enhanced interactions with CCR5.
Mefford ME; Kunstman K; Wolinsky SM; Gabuzda D
Virology; 2015 Jul; 481():210-22. PubMed ID: 25797607
[TBL] [Abstract][Full Text] [Related]
17. Viral determinants of HIV-1 macrophage tropism.
Duncan CJ; Sattentau QJ
Viruses; 2011 Nov; 3(11):2255-79. PubMed ID: 22163344
[TBL] [Abstract][Full Text] [Related]
18. Cell-type specific requirements for thiol/disulfide exchange during HIV-1 entry and infection.
Stantchev TS; Paciga M; Lankford CR; Schwartzkopff F; Broder CC; Clouse KA
Retrovirology; 2012 Dec; 9():97. PubMed ID: 23206338
[TBL] [Abstract][Full Text] [Related]
19. Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition.
Panos G; Watson DC
Crit Rev Microbiol; 2015; 41(4):473-87. PubMed ID: 24635642
[TBL] [Abstract][Full Text] [Related]
20. The evolution of HIV-1 entry phenotypes as a guide to changing target cells.
Joseph SB; Swanstrom R
J Leukoc Biol; 2018 Mar; 103(3):421-431. PubMed ID: 29389021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
